American International Group’s Ginkgo Bioworks DNA Stock Holding History

American International Group’s Portfolio DNA Stock Details DNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-354	Closed	-$16.4K	–	763
2024 Q1	$16.4K	Buy	354 +4	+1%	+$207	﹤0.01%	2950
2023 Q4	$23.7K	Sell	350 -5	-1%	-$306	﹤0.01%	2948
2023 Q3	$25.7K	Sell	355 -21	-6%	-$1.68K	﹤0.01%	2959
2023 Q2	$28K	Buy	376 +136	+57%	+$8.05K	﹤0.01%	2989
2023 Q1	$12.7K	Sell	240 -5	-2%	-$317	﹤0.01%	2935
2022 Q4	$16.6K	Buy	245 +8	+3%	+$736	﹤0.01%	2947
2022 Q3	$30K	Buy	237 +1	+0.4%	+$119	﹤0.01%	2931
2022 Q2	$22K	Buy	+236	New	+$28.8K	﹤0.01%	3003

Other funds holding DNA

Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

ACG

Anchorage Capital Group New York $450M AUM 41.75% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

Legal & General Group London, United Kingdom $480B AUM 42.84% 1-Year Est. Return

GCM

Glenview Capital Management New York $5.49B AUM 46.89% 1-Year Est. Return

SIAU

SB Investment Advisers (UK) London, United Kingdom $7.66B AUM 20.12% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return

American International Group's DNA Position: Q2 2024 in Review

American International Group sold out of Ginkgo Bioworks (DNA) in Q2 2024, closing a stake of 354 shares — an estimated $16.4K sold.

American International Group first reported a position in DNA in Q2 2022 and held it in 8 quarters. The position peaked at $30K in Q3 2022. 313 funds tracked by Wall St. Rank hold DNA as of Q2 2024.

American International Group reported no remaining Ginkgo Bioworks position as of Q2 2024 after selling out during the quarter.
American International Group sold 354 Ginkgo Bioworks shares in Q2 2024, an estimated $16.4K.
American International Group first reported a position in Ginkgo Bioworks in Q2 2022 and held it in 8 quarters.
American International Group's Ginkgo Bioworks position peaked at $30K in Q3 2022.
313 funds tracked by Wall St. Rank held Ginkgo Bioworks as of Q2 2024.

Based on American International Group's 13F filing for Q2 2024, filed 13 Aug 2024.